Zhilin Qi
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 4
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds 6
- Flavonoids in Medical Research 6
- Toxicology top 5%
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research 4
-
- Heat shock proteins research 6
- Natural product bioactivities and synthesis 5
- Medicinal Plants and Bioactive Compounds 4
- Journals
- PLoS ONE (1 paper)Biochemical and Biophysical Research Communications (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- ChinaSaint Kitts and Nevis
In The Last Decade
Zhilin Qi
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 211
- Pharmacology 112
- Complementary and alternative medicine 89
- Toxicology 36
- Clinical Biochemistry 71
Countries citing papers authored by Zhilin Qi
This map shows the geographic impact of Zhilin Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhilin Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhilin Qi more than expected).
Fields of papers citing papers by Zhilin Qi
This network shows the impact of papers produced by Zhilin Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhilin Qi. The network helps show where Zhilin Qi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhilin Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 21 | |
| 5 | 2020 | 16 | |
| 6 | 2020 | 45 | |
| 7 | 2019 | 23 | |
| 8 | 2019 | 23 | |
| 9 | 2017 | 28 | |
| 10 | 2017 | 63 | |
| 11 | 2017 | 90 | |
| 12 | 2016 | 2 | |
| 13 | 2016 | 24 | |
| 14 | 2016 | 60 | |
| 15 | 2015 | 23 | |
| 16 | 2014 | 39 | |
| 17 | 2014 | 33 | |
| 18 | 2014 | 17 | |
| 19 | [Effect of MHSP65-TCL anti-melanoma vaccine on the activity of immunocytes]. | 2013 | 1 |
| 20 | 2013 | 95 |
About Zhilin Qi
Zhilin Qi is a scholar working on Clinical Biochemistry, Pharmacology and Cancer Research, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (6 papers), Heat shock proteins research (6 papers), Flavonoids in Medical Research (6 papers), Natural product bioactivities and synthesis (5 papers), Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers), Advanced Glycation End Products research (4 papers) and Medicinal Plants and Bioactive Compounds (4 papers). The work is most often cited by research in Cancer Research (211 citations), Pharmacology (112 citations) and Complementary and alternative medicine (89 citations). Zhilin Qi has collaborated with scholars based in China and Saint Kitts and Nevis. Frequent co-authors include Shimei Qi, Yao Zhang, Zunyong Feng, Lei Lan, Liefeng Ling, Liang Yan, Zhimin Yin, Tao Hong, Lei Shen and Jun Lv. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.